Hearing Loss Trial, Recruiting NCT06112860 Sponsor: Northwestern University Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06112860
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 60 years of age
  • People who have been diagnosed with mild dementia or mild cognitive impairment at a participating memory evaluation centre
  • People who have mild to moderate hearing loss in both ears and are not currently using hearing aids
  • People who have a family member, friend, or carer who is willing and able to take part in the study alongside them
  • People whose vision is not severely impaired in a way that would prevent them from completing study tasks (for example, people who are not legally blind and do not have severe cataracts or macular degeneration)
  • People who are able to give their own consent to participate, as assessed by a consent evaluation process

Who may not be able to join:

  • People who have a serious, unstable, or worsening medical condition that the trial investigators consider would put them at unacceptable risk by participating
  • People who have ongoing communication difficulties as a result of another neurological condition such as a stroke or brain tumour, a neurodevelopmental condition such as Down's syndrome, or head or neck cancer
  • People who have a history of a major psychiatric condition such as schizophrenia, or significant depression that has not been treated
  • People who are already taking part in another study that focuses on hearing, language, or communication
  • People who have a history of, or currently experience, hearing loss that fluctuates or changes over time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pamela Souza, PhD, Northwestern University

Phone: 8474670897

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 July 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Perception of Conversation Index - Dementia Alzheimer's Type (PCI-DAT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov